1 The effect of quinolinic acid, N-methyl-D,L-aspartate (NMDLA) and kainate on the release of endogenous and exogenous amino acids from the rat cerebral cortex in vitro and in vivo was studied. 2 Neither quinolinic acid nor NMDLA had any effect on the basal or potassium-evoked release of [3H]-D-aspartate from slices of rat cerebral cortex either in the presence or absence of magnesium. Kainic acid failed to modify the basal efflux of [3H]-D-aspartate but significantly inhibited (by 34.4% ± 0.04%, P < 0.05) the potassium-evoked release. 3 Neither quinolinate nor NMDLA had any effect on the basal efflux of endogenous amino acids from rat cortical slices either in the presence or absence of magnesium ions at concentrations between 10pFM and 5 mM. 4 Both NMDLA (1 mM) and quinolinate (5mM) produced an efflux of endogenous aspartate (371.4% + 11.6%; 389.3% + 12.1%) and glutamate (405.4% + 13.6%; 430.1 + 8.7%) respectively from the rat cerebral cortex in vivo (P < 0.01). The quinolinic acid-evoked effiux was abolished by the NMDLA antagonist, 2-amino-5-phosphonovaleric acid (200pM). 5 Kainic acid also caused an efflux of endogenous amino acids from the rat cerebral cortex in vivo. However, the profile of this release was different from that produced by quinolinate and NMDLA. 6 The results add further support to the suggestion that quinolinic acid acts at the NMDLApreferring receptor and may also explain the requirement for intact afferent projections for the neurotoxic effects of quinolinate to be manifested.
Introduction
There is now considerable electrophysiological and biochemical evidence to suggest that the endogenous tryptophan metabolite, quinolinic acid, acts selectively on the N-methyl-D,L-aspartate (NMDLA) type of amino acid receptor to produce excitation of central neurones , Stone et al., 1987 . In addition to its potent excitatory activity, quinolinic acid is capable of producing convulsions when given intracerebroventricularly to mice (Lapin, 1981) and is a kainate-like neurotoxin producing axon-sparing lesions following injection into several regions of the CNS (Schwarcz et al., 1983) .
Kainic acid, however, has been proposed to act, at least in part, by inhibition of the reuptake of released acidic amino acids (McGeer & McGeer, 1982) thereby increasing the concentrations of these amino 1 Author for correspondence. acids in the synaptic cleft. In addition, Ferkany & Coyle (1983) have shown that kainate can promote a calcium-dependent release of glutamate and aspartate from both rat and mouse hippocampus and cerebellum. These findings have been tendered in partial explanation of the requirement for putative glutamatergic afferent pathways to be present in order for kainate to produce toxicity (Biziere & Coyle, 1978) .
Quinolinic acid has also been shown to require such afferent projections in order to manifest its neurotoxic effects (Schwarcz et al., 1984) . The possibility existed therefore that quinolinic acid might also act in part indirectly, either inhibiting the reuptake of acidic amino acids, or causing their release, in addition to any direct postsynaptic effects. We have therefore investigated the possible modulation of amino acid release and uptake by quinolinic acid and other related compounds.
Methods
Preparation of rat cortical brain slices Male Wistar rats were killed by decapitation after stunning and the occipital, interparietal, parietal and frontal bones of the skull removed. The dura was removed with a pair of fine forceps and the neocortex of each cerebral hemisphere separated by a cut parallel to the surface of the cortex. The slice (approximately 1.5mm thick) was then placed in ice cold Krebs-bicarbonate solution (composition, mM: KH2PO4 2.2, MgSO4 1.2, KCl 2.0, glucose 10.0, NaHCO3 25.0, NaCl 115.0, CaCI2 2.5). The neocortical slice was Slices were then sedimented by brief centrifugation and the supernatant discarded. Pellets were then stored at -20'C for protein determination (Lowry et al., 1951) .
Surgical procedurefor the preparation ofa cortical cup Male Wistar rats were anaesthetized with urethane (1.3-1.7mgkg-1). The rat was mounted in a stereotaxic head frame and the body temperature (rectal) maintained at approximately 370C by an overhead lamp.
The neck muscles were dissected and the cerebrospinal fluid (CSF) drained from the cisterna magna through a puncture made in the posterior atlantooccipital membrane. This usually prevented the development of cerebral oedema throughout the experiment. When there was a cerebral oedema in spite of CSF drainage, the results were rejected.
A craniotomy was performed and the dura reflected to expose the cortical surface between the coronal and lambdoid sutures Turnell & Cooper (1982) : o-phthalaldehyde (OPT)/2-mercaptoethanol derivatives were produced by taking 100y1 of OPT reagent solution (Sigma) and mixing with 1001l of amino acid mixture (Standards or sample). The mixture was immediately vortexed to produce the 1-alkyl-thio-2-alkyl-substituted iso- indole derivative (Roth, 1971 Solvent B consisted of water (400ml), acetonitrile (300 ml) and methanol (300 ml) premixed and filtered under vacuum.
Chromatographic conditions: the gradient programme consisting of a series of linear steps; expressed as time in min from injection (% solvent B) was; 0(0), 10(0), 30(100). The flow rate was 1.5 ml min 1 at room temperature.
Quantification: amino acid derivatives were identified by their retention times relative to a reference injection of standard amino acids injected every 10 samples. The amino acid concentrations were quantified by comparing the peak heights to those obtained in the reference injection. This method was found to provide an accurate and reliable means of quantification (Connick, 1987) . In some cases the resolution of the peaks for y-aminobutyric acid (GABA) and alanine was not sufficient for accurate quantification (i.e. when peaks were not separated to the baseline) and in these cases the offending amino acid has been omitted from the results. . Even at 1 mM, however, kainate had no effect on the basal efflux of [3H]-D-aspartate (Table 1) , and actually inhibited the potassium-evoked release of
[3H]-D-aspartate (by 34.4% + 0.04%, n = 8, P < 0.05).
Release ofendogenous amino acids in vitro
The concentrations of endogenous amino acids released into the medium under control conditions are n 8 8 8 (Table 2 ). Lower concentrations of both NMDLA and quinolinate (10pM and 100pM) also failed to produce any observable effect (data not shown). This lack of activity was also found in rat hippocampal slices (Connick & Stone, 1986) . In order to ensure that the lack of activity of quinolinic acid in inducing amino acid release in vitro was not due to any problems associated with the preparation of the tissue, similar experiments were repeated in vivo.
Release ofendogenous amino acids in vivo
In this study we have used the cortical cup technique to follow the overflow of endogenous amino acids from the cortex. Preliminary experiments emphasised the need for extreme care during the surgery involved. Even the smallest damage to the pial surface produced variable results, and generated a vastly greater acid release. In addition great care was necessary in attaching the plastic cylinder to the cortex, so as not to damage the superficial blood supply.
In order to ensure that the pial surface was intact, and to show that any changes in amino acid levels were not due to plasma contamination, the impermeant extracellular space marker [51Cr]-EDTA was used in a number of experiments. Only 0.6% + 0.1% (n = 4) of the label present in the plasma was found in the cup with the intact cortex. This rose to 9.2% + 1.2% (n = 4) following mild damage to the cortical surface with a hypodermic needle. This amount was equivalent to the activity found in both the cortex itself and hind limb muscle.
Effect ofquinolinic acid in vivo
The concentrations of endogenous amino acids released into the medium under control conditions are presented in Table 3 . Whilst 1 mm quinolinic acid slightly increased the mean percentage efflux of both aspartate and glutamate, the results were not significant (data not shown). At 2mM, however, quinolinate caused a large and highly specific increase in the release of aspartate (191.5% + 15.6% of mean) and glutamate (180.2% + 13.4% of mean). The efflux of other amino acids (serine, glycine, glutamine, alanine, and GABA) was not significantly changed.
At 5 mm quinolinate produced a greater increase in the release of aspartate (389.3% + 12.1% of mean) and glutamate (430.1% + 8.7% of mean) (Figure 1) , and in addition at this concentration, the efflux of serine, glycine and taurine was also increased. In contrast to the results obtained in neutral saline, Figure 1 The effect of 5mM quinolinic acid on the basal efflux of endogenous amino acids from the rat cerebral cortex in vivo. Amino acid efflux was determined as described in the text with the inclusion of 5mM quinolinic acid in the neutral saline solution for the second 10min 'stimulation' period. Results are mean % control efflux from 11 experiments with s.e. mean shown by vertical lines. Solid columns, control; hatched columns, 5 mm quinolinic acid. Asp = aspartate; Glu = glutamate; Ser = serine; Gly = glycine; Gln = glutamine; Ala = alanine; Tau = taurine. 5mM quinolinic acid in Krebs-bicarbonate medium had no effect (Figure 2) Effect of NMDLA NMDLA (1 mM) evoked a similar specific release of aspartate (371.4% + 11.4% of mean) and glutamate (405.4% + 13.6% of mean) to that evoked by 5mM quinolinate. Whilst the response to NMDLA was severely reduced in Krebs-bicarbonate medium (by over 60%), in common with quinolinic acid (Figure  2) , it remained significantly different from control (P < 0.05). Removal of magnesium ions from the medium, however, increased the response to NMDLA to over 75% of that obtained in saline.
Effect of kainic acid
Whereas the NMDLA-receptor agonists tested showed a response in vivo but not in vitro, kainic acid at 2 mm, which produced a significant increase Figure 4 The effect of 2 mm and 5mM kainic acid on the basal effiux of endogenous amino acids from the rat cerebral cortex in vivo. Amino acid effiux was determined as described in the text with the inclusion of (a) 2 mm kainic acid, or (b) 5 mM kainic acid in the neutral saline solution for the second 10 min 'stimulation' period. Solid columns, control; hatched columns, plus kainate. For abbreviations, see Figure 1 . Results are mean % control efflux from 7 and 10 experiments respectively with s.e. mean shown by vertical lines.
in amino acid efflux in vitro in rat hippocampal slices (Connick & Stone, 1986) was without demonstrable effect in vivo (Figure 4) Lehmann et al. (1983a) have demonstrated the release of acetylcholine from striatal slices by both NMDLA and quinolinate in vitro. These authors reported the absolute dependence of this release on the absence of magnesium ions from the medium. In the presence of 1 mm magnesium, no release could be demonstrated. However, no effect of either agonist against amino acid release could be demonstrated in our system, either in the presence or absence of magnesium. Our results thus confirm the absence of an NMDLA response reported by Ferkany & Coyle (1983) . The different results obtained on acetylcholine release and amino acid release may reflect activation of different cell populations, or a difference in sensitivity of striatal and neocortical tissue.
It is most surprising that in such comparatively high doses neither NMDLA nor quinolinate produce any tissue damage, which might be expected to cause the leakage of amino acids into the medium at the very least. It is possible that in high concentrations these compounds cause desensitization of their receptors (Addae & Stone, 1986) , or overdepolarization of the tissue. Since much lower concentrations of quinolinate and NMDLA also had no effect on release, this would appear unlikely.
Excitatory amino acids and release in vivo
In contrast to the lack of effect of quinolinic acid and NMDLA in evoking release of either radiolabeled Daspartate or endogenous glutamate and aspartate in vitro, both agonists proved to have powerful effects in vivo.
Preliminary experiments using the agonists dissolved in pregassed neutral saline showed the largest stimulation of release by both compounds. In a study of the effects of topically applied exogenous amino acids on evoked potentials in the rat cerebral cortex Addae & Stone (1986) found no difference between the use of 0.9% sodium chloride and Krebs solution, saline being more convenient due to problems of precipitation encountered during static incubations with Krebs-bicarbonate solution. Whilst the use of saline might be criticised on the grounds that ion levels in the cortex might become depleted, such depletion of ion levels in the cortex has been shown to be exceedingly difficult (Fagg & Lane, 1979) .
The resting release of all the amino acids studied here (Table 3) were similar to those obtained in an earlier paper by Clark & Collins (1976) . Thus aspartate accounted for 10.7% of the total resting amino acid efflux and glutamate 24%, both very similar to the results of Clark & Collins (1976) . GABA release was 2.8% of the total, however, approximately twice that found by Clark & Collins (1976) while taurine was 6.5% of the total, compared with 10% found in the earlier study (Clark & Collins, 1976) .
In these experiments, rats have been anaesthetized with urethane. This anaesthetic has been reported to have weak amino acid antagonist activity (Evans & Smith, 1982) . Thus it is possible that the values of evoked release are an underestimate of those which may occur in awake animals.
The maximum response to both NMDLA and quinolinate was obtained in neutral saline, whilst Krebs-bicarbonate solution severely attenuated the response. An increased response could be restored by omitting magnesium. The magnesium sensitivity of quinolinic acid-evoked efflux, together with the action of APV (Figure 3) , confirm that quinolinate is indeed acting at the NMDLA receptor subclass, or at least at a proportion of them.
Whereas the NMDLA receptor agonists tested showed a response in vivo but not in vitro, kainic acid at 2 mm, which produced a significant increase in amino acid efflux in vitro (Ferkany and Coyle, 1983; Connick & Stone, 1986 ) was without demonstrable effect in vivo. Increasing the dose of kainate to 5 mm, however, caused a large efflux of almost all the amino acids detected.
Autoradiographic evidence concerning the distribution of kainate receptors suggests that whereas NMDLA displaces bound glutamate in the upper layers of the cortex, kainate receptors are only found in the deeper cortical layers (Greenamyre et al., 1985) . Thus whilst 2 mm kainate had no demonstrable effect on amino acid release monitored at the cortical surface, it is possible that a similar release to that which occurs in vitro took place in the deeper layers, but was masked by the reuptake of the released amino acids in more superficial layers. The increase of extracellular taurine may reflect its reuptake by brain tissue, which is far less avid than that for glutamate and aspartate (Richelson & Thomson, 1973 (1982) . Whilst this technique does provide major advantages, in that it allows the investigation of various deep neuronal structures in freely moving or anaesthetized animals, the inevitable tissue damage associated with passing a steel probe vertically through the brain of an animal produces a number of problems, notably considerable glial invasion of the damaged tissue ( Figure highly active tissue is therefore produced between the intact brain and the dialysis probe, which may not therefore provide a true reflection of the area of brain under investigation. Vezzani et al. (1985) using this dialysis technique, found that focal injections of high concentrations of quinolinate into the rat hippocampus caused an increase in the efflux of taurine (224% of control), with no change in the efflux of the two other amino acids monitored (glutamate and glycine). Lehmann et al. (1985) , reported a marked increase in taurine efflux from rabbit hippocampus in response to both NMDLA and quinolinate. In addition the increased efflux of phosphoethanolamine (PEA) was demonstrated. These increases were large; taurine was increased to 1200%, and PEA to 2400% of their resting levels in response to 5mM NMDLA. Although the efflux of other amino acids was not reported in detail, the authors observed that 'most other amino acids rose by 20-100%'. In comparison with 5 mM NMDLA, 5 mM quinolinate increased extracellular taurine to 800% of control and PEA by 1500%. It should be noted that the ratio of taurine to PEA for NMDLA was 0.5, whilst in the case of quinolinate it was 0.53. Addition of 5mM APV reduced the 5mM NMDLA-induced efflux of both taurine and PEA by 90%.
It is interesting that the same authors were unable to detect any effect of NMDLA (up to 5mM) on taurine (and probably other amino acid) efflux from a synaptosome preparation (Lehmann et al., 1985) . Lehmann et al. (1983b) , had previously investigated the effect of kainic acid on the efflux of amino acids from the rabbit hippocampus using dialysis techniques. Again, the efflux of aspartate was not monitored (or at least not reported), but an increased efflux of glutamate, taurine and PEA was found in response to 1 mM kainate. Long perfusion periods with higher concentrations of kainate increased the levels of 'virtually all amino acids', which may be interpreted as reflecting the inability of brain tissue to retain low molecular weight substances in the presence of kainate. This may represent an early sign of cell damage.
The only other in vivo study on the effect of NMDLA and quinolinic acid on release was an examination of tritiated purine release. Perkins & Stone (1983) found that both NMDLA and quinolinate produced the release of tritiated purines from the rat cerebral cortex in vivo. Kynurenic acid did not evoke any release by itself, but did act to block the effect of both quinolinate and NMDLA. Attempts to repeat this work in vitro with brain slices, were without success (H.G.E. Lloyd and T.W. Stone, unpublished observations). Jacobson & Hamberger (1985) found that kainate caused a rapid increase in the release of aspartate, glutamate, GABA, PEA and taurine in the rabbit olfactory bulb in vivo. Whilst slices of olfactory cortex also showed an increased efflux of aspartate and glutamate in response to kainate, other amino acids were unaffected. The authors therefore concluded that certain tissue properties were not reflected in vitro.
In summary, with the exception of the quinolinic acid-and NMDLA-evoked release of acetylcholine from striatal slices (Lehmann et al., 1983a) , all other attempts to produce an effect on amino acid release using agonists at the NMDLA receptor in vitro have failed. The reasons for these obvious differences between the results obtained in vitro and those in vivo are unknown. It is possible that some factor which facilitates amino acid release is lost during the preparation of the brain slices, or that some inhibitory factor is released. Alternatively the differences may simply reflect the higher level of excitability in vivo resulting from the constant afferent stimulation.
When considering quinolinic acid as an endogenous agonist at the NMDLA receptor, these negative effects in vitro may be used as supporting evidence, since none of the results differentiate quinolinate from NMDLA; i.e. they are pharmacologically identical. In addition both compounds can be blocked by APV in vivo and the results thus clearly discriminate between quinolinate and kainate, which evokes a pronounced amino acid release even in vitro. Thus whilst some of the neurodegenerative properties of quinolinate resemble those of kainate more than NMDLA (Stone et al., 1987) , this cannot be explained by a releasing action upon the same amino acid pool.
The excitotoxic hypothesis states that the neurotoxic effects of acidic amino acids result from a direct interaction with specific receptors, located on susceptible neurones, causing excessive depolarization and neuronal death (Olney, 1980) . The neurodegeneration produced by quinolinic acid, like that of kainate, cannot be explained simply in these terms since it is dependent upon intact (glutamatergic) synaptic input and it shows greater than expected neurotoxic potency as compared with the apparent potency of other NMDLA agonists when tested electrophysiologically .
Clearly these requirements suggest an interaction between quinolinate and a non synaptic region, located either on the dendrites or on the cell body. Quinolinate may activate presynaptic terminals, directly or indirectly to cause increased release of the neurotransmitter, which in turn interacts with postsynaptic NMDLA receptors to produce cell death. The first direct support for this hypothesis is the present demonstration of the release of aspartate and glutamate by quinolinate in vivo. This mechanism explains why quinolinate induced neurotoxicity requires the involvement of an excitatory amino acid releasing input.
